New Cell Therapy Shows Promise with ARDS Patients
https://reachmd.com/news/new-cell-therapy-shows-promise-with-ards-patients/2457085/
Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe Covid-19. Published in the journal Nature Communications, Professor Justin Stebbing of Anglia Ru…
Researchers Identify Protein That Controls CAR T-Cell Longevity
https://reachmd.com/news/researchers-identify-protein-that-controls-car-t-cell-longevity/2462703/
Like a lightbulb, CAR T cells designed to kill cancer often burn out due to exhaustion and poor persistence. Doan et al. discovered that a transcription factor called FOXO1 is responsible for keeping the CAR T lightbulb energi…
Why Some Tumors Are Resistant to Cell Therapies
https://reachmd.com/news/why-some-tumors-are-resistant-to-cell-therapies/2467221/
FRANKFURT. In congratulating the CARISMa scientists, Goethe University President Prof. Enrico Schleiff said: “The new LOEWE network sets up in Hesse an innovative research program that is currently gathering steam all over the world. It also expands Goethe …
ResearchPharmacological Inhibitor Protects Nerve Cells in ALS Disease
https://reachmd.com/news/researchpharmacological-inhibitor-protects-nerve-cells-in-als-disease/2457127/
ALS is a degenerative disease of the nervous system particularly affecting and harmful to motor neurons. As the disease progresses, the nerve cells controlling voluntary muscle movement die. That leads to a progressive wasting of the muscles responsible for moving and speaking, but also for eating …
Targeting Vulnerability in B-Cell Development Leads to Novel Drug Combination for Leukemia
https://reachmd.com/news/targeting-vulnerability-in-b-cell-development-leads-to-novel-drug-combination-for-leukemia/2462651/
B-cell development stage is a challenge and vulnerability in B-ALL B-ALL is a cancer derived from white blood cells called B cells. Under normal circumstances, B cells develop from immature to fully mature, passing through eight steps. In cancers, cells can get stuck in an intermediate stage …
Promising Target for CAR T-Cell Therapy Leads to Potent Antitumor Responses Against Cutaneous and Rare Melanomas
https://reachmd.com/news/promising-target-for-car-t-cell-therapy-leads-to-potent-antitumor-responses-against-cutaneous-and-rare-melanomas/2457214/
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.CAR T-cell therapy use…
New Glioblastoma Treatment Reaches Human Brain Tumor and Helps Immune Cells Recognize Cancer Cells
https://reachmd.com/news/new-glioblastoma-treatment-reaches-human-brain-tumor-and-helps-immune-cells-recognize-cancer-cells/2466965/
Credit: Pixabay/CC0 Public Domain In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists have used ultrasound technology to penetrate the blood-…
Scientists Identify Airway Cells That Sense Aspirated Water and Acid Reflux
https://reachmd.com/news/scientists-identify-airway-cells-that-sense-aspirated-water-and-acid-reflux/2462801/
Credit: Unsplash/CC0 Public Domain When a mouthful of water goes down the wrong pipe—heading toward a healthy person's lungs instead of their gut—they start coughing uncontrollably. That's because the…
How 'Late-Rising' T Cells Combat a Stubborn Virus
https://reachmd.com/news/how-late-rising-t-cells-combat-a-stubborn-virus/2457052/
video: La…
Mathematical Model Exploits Cancer Cell Plasticity to Guide Adaptive Therapy
https://reachmd.com/news/mathematical-model-exploits-cancer-cell-plasticity-to-guide-adaptive-therapy/2463211/
During treatment breaks, an increase in drug-sensitive cells is observed due to changes in plastic cancer cells. With minimum dosage treatment, the growth of drug-resistant cancer cells is suppressed. Subsequently, the applica…